Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as cyclophosphamide and dexamethasone work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. Bortezomib may stop the growth of cancer cells by blocking some of the
enzymes needed for cell growth. Giving cyclophosphamide and dexamethasone together with
bortezomib may kill more cancer cells.
PURPOSE: This phase II trial is studying giving cyclophosphamide and dexamethasone together
with bortezomib to see how well it works in treating patients with newly diagnosed multiple
myeloma.